Markets.com Logo

AFMD

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.217$
  • Previous Close
    0.1829$
  • 52 Week Change
    8.88$
  • Day Range
    0.03$
  • 52 Week High/Low
    0.0701$ - 8.95$
  • Dividend Per Share
    --
  • Market cap
    2 975 K$
  • EPS
    -0.94
  • Beta
    2.072
  • Volume
    --

About

AFMD.US represents the common stock of Affimed N.V., a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. Their proprietary ROCK platform enables the development of innate cell engagers (ICEs), designed to direct and harness the power of the innate immune system to fight cancer. Affimed's lead product candidate, AFM13, is being investigated in clinical trials for the treatment of CD30-positive lymphomas, and the company has several other ICEs in preclinical development targeting various cancers.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Clinical Trial Results: Positive clinical trial outcomes typically boost investor confidence and drive up the stock price. Conversely, failed or delayed trials can negatively impact the stock.

Regulatory Approvals: Successful approval of Afmd's product candidates by regulatory agencies like the FDA can lead to increased stock value.

Partnerships and Collaborations: Strategic alliances with larger pharmaceutical companies or research institutions often signal validation of Afmd's technology and can influence stock performance.

Market Sentiment: Overall market conditions and investor sentiment towards the biotechnology sector can affect Afmd's stock price, regardless of company-specific news.

Financial Performance: Afmd's cash position, revenue generation, and expenses influence investor perception and stock valuation. Strong financial results typically lead to increased confidence.

Competition: The presence of competing therapies or companies in the same therapeutic area can impact Afmd's market share and stock price.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--